Pharmaceuticals and life sciences

PwC advises on delivery models for the HR function, the role of line management and balancing the needs for value, service, and cost efficiency.

The supply chain of the future will be built around flexibility, responsiveness and reliability shifting the supply paradigm from a stock-based model to an order-based model.

The scope of these challenges, like the industry itself, has grown global - and so have the attendant risks.

Companies need to assess the best way to make technological investments in research and development (R&D) and supply chain.

No matter which direction you choose, such planning can result in improved cash flow and a reduction in the overall effective tax rate.

Our team will assist you in defining your strategy and business plans as you meet the challenges of a changing environment.

We have teams working closely with leading payers and providers across the globe, and we understand the issues around the use (and cost) of pharmaceutical products from both their perspectives and yours.

Our specialists offer a full range of services, from inception to post-deal integration.

We know how to manage and sustain change in the R&D environment.

The challenges that Pharmaceuticals CEOs perceive are—perhaps not surprisingly—the same issues that we at PwC confront every day.